HTA229 PICO Criteria Applied in Joint Action 3 Differ From National HTA Requirements: A Review of Oncology Drug Assessments in Denmark, France, Germany, and Sweden
| Autor: | Konstanski, M., Gehrman, J., Schepis Martinez, J., Schmidt, K., Wissinger, E., Altmann, H. |
|---|---|
| Zdroj: | In Value in Health December 2023 26(12) Supplement:S363-S364 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect